In 2025, about 200-300 million people worldwide take antidepressants for depression, anxiety, and other mood disorders. These drugs, like SSRIs and SNRIs, balance brain chemicals to ease symptoms. Depression affects 332 million adults, anxiety over 300 million, but treatment gaps leave 75% in low-income countries without help. High-income nations see 7.2% usage, led by Iceland, […]